Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 34 clinical trials
Effect of Avastin in Juxtafoveal Telangiectasias

Evaluation of efficacy of Intravitreal Injection of Bevacizumab in patients with Yuxtafoveal Telangiectasias

  • 2 views
  • 07 Nov, 2020
  • 1 location
Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer

The purpose of this randomized clinical study is to confirm the utility of chemosensitivity (ChemoID) tumor testing on cancer stem cells as a predictor of clinical response in recurrent epithelial ovarian cancer (EOC), fallopian tube, or primary peritoneal cancer, regardless of platinum sensitivity. Population studied will be female participants experiencing …

measurable disease
avastin
ovarian epithelial cancer
metastasis
peritoneal cancer
  • 113 views
  • 25 Jan, 2021
  • 3 locations
Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone in Patients With Neovascular Age Related Macular Degeneration (AMD)

This is s randomized, multi-center, double blind, 3 arm, phase I/II pilot study to evaluate the safety and efficacy of treatment with ORA102 combined with Avastin (Bevacizumab) versus

avastin
age-related macular degeneration
corrected visual acuity
bevacizumab
  • 30 views
  • 07 Nov, 2020
  • 1 location
Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma

The purpose of this study is to evaluate the efficacy and safety of avastin combined with gemcitabine, oxaliplatin, pegaspargase and dexamethasone(Avastin+ GemAOD) as first-line treatment in

  • 9 views
  • 07 Nov, 2020
  • 1 location
Central Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.

The purpose of this study is to determine whether Bevacizumab (Avastin) in combination with Dexamethasone (Ozurdex) will be effective in reducing if not eliminating the macular edema associated

  • 0 views
  • 25 Jan, 2021
  • 1 location
A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

This is a Phase II, multicenterrandomized, two arms, open-labeled, controlled clinical trial. This trial was conducted to evaluate the efficacy and safety of bevacizumab (Avastin) plus mXELIRI

proteinuria
metastasis
liver metastasis
chemotherapy regimen
fluorouracil
  • 1 views
  • 05 Feb, 2021
  • 1 location
Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery

This study analyzes the safety and efficacy of off-label Subconjunctival Injection of bevacizumab (Avastin) versus 0.02% mitomycin C (MMC) for preventing bleb failure following glaucoma

cataract
trabeculectomy
subconjunctival injection
intraocular pressure
mitomycin
  • 28 views
  • 07 Nov, 2020
  • 1 location
Intravitreal Bevacizumab for Retinal Disorders

Injection of bevacizumab (Avastin) for CNVM, Macular oedema due to diabetic retinopathy, vascular occlusion and other retinal disorders.

macular degeneration
diabetic retinopathy
avastin
vascular endothelial growth factor
venous occlusion
  • 23 views
  • 07 Nov, 2020
  • 1 location
The Sahlgrenska Anti-VEGF Study

The study investigates whether patients treated for neovascular (wet) age-related macular degeneration (AMD), with intravitreal injection with bevacizumab (Avastin) after two years need more

  • 0 views
  • 04 Feb, 2021
  • 1 location
FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer

FOLFOX4 plus Avastin has been suggested as firstline regimen for advanced colorectal cancer by NCCN, a new angiogenesis inhibitor, known as Endostar(Recombinant Human Endostatin

measurable disease
avastin
lung cancer
  • 12 views
  • 07 Nov, 2020
  • 1 location